Lilly announces departure of chief financial officer, Anat Ashkenazi
Eli Lilly and Co. announced Tuesday that Anat Ashkenazi has resigned as chief financial officer to pursue a career opportunity outside of the pharmaceutical industry. Ms. Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly’s Executive Committee through July 2024.